Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNIFFLE-2: LAIV in Egg Allergic Children
NCT02111512Phase 4Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Sep 2014
- Primary completion
- Feb 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of live attenuated influenza vaccine in influenza, sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Incidence of allergic reaction to nasal influenza vaccination using a Live Attenuated Influenza Vaccine (LAIV) in egg-allergic children at 2 hours. Started Sep 2014; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02111512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02111512.